Effect of Soy Isoflavones on Bone Mineral Density and Physical Performance Indices
SoyPTI
The Effect of Increased Soy Protein Intake on Bone Metabolism
1 other identifier
interventional
203
1 country
1
Brief Summary
The aim of the present study was to investigate the effects of soy and soy plus isoflavones on bone mineral Density and physical performance in post menopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2001
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2004
CompletedFirst Submitted
Initial submission to the registry
April 17, 2008
CompletedFirst Posted
Study publicly available on registry
April 21, 2008
CompletedApril 21, 2008
April 1, 2008
3 years
April 17, 2008
April 17, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bone Mineral Density
24 months
Secondary Outcomes (1)
Physical Performance Indices
24 months
Study Arms (3)
1
ACTIVE COMPARATORSoy Protein group 25g of Soy protein with no Isoflavones
2
EXPERIMENTALSoy Isoflavone group 25g of Soy Protein with 90mg of Isoflavones
3
PLACEBO COMPARATOR25g of Milk protein
Interventions
25g of Soy protein with or with out 90mg of isoflavones ones a day given for a period of 24 months
Eligibility Criteria
You may qualify if:
- at least 55-75 years of age
- at least 7 years post menopausal either spontaneous or surgical
You may not qualify if:
- must not have used estrogen for atleast 2 months prior to entering study
- must be on no bone active drugs such as bisphosphonates, anti convulsants, calcitonin and long term steroids
- osteoporosis (T-score\<-2.5)
- BMI \<18 or \>34
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Creighton Universitylead
- Solae, LLCcollaborator
Study Sites (1)
Creighton University Medical Center
Omaha, Nebraska, 68131, United States
Related Publications (1)
Gallagher JC, Satpathy R, Rafferty K, Haynatzka V. The effect of soy protein isolate on bone metabolism. Menopause. 2004 May-Jun;11(3):290-8. doi: 10.1097/01.gme.0000097845.95550.71.
PMID: 15167308BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
J C Gallagher
Creighton University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 17, 2008
First Posted
April 21, 2008
Study Start
January 1, 2001
Primary Completion
January 1, 2004
Study Completion
January 1, 2004
Last Updated
April 21, 2008
Record last verified: 2008-04